Research ArticleBasic Sciences
Reduction of Background Activities by Introduction of a Diester Linkage Between Antibody and a Chelate in Radioimmunodetection of Tumor
C.H. Paik, K. Yokoyama, J.C. Reynolds, S.M. Quadri, C.Y. Min, S.Y. Shin, P. J. Maloney, S. M. Larson and R. C. Reba
Journal of Nuclear Medicine October 1989, 30 (10) 1693-1701;
C.H. Paik
K. Yokoyama
J.C. Reynolds
S.M. Quadri
C.Y. Min
S.Y. Shin
P. J. Maloney
S. M. Larson
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Reduction of Background Activities by Introduction of a Diester Linkage Between Antibody and a Chelate in Radioimmunodetection of Tumor
C.H. Paik, K. Yokoyama, J.C. Reynolds, S.M. Quadri, C.Y. Min, S.Y. Shin, P. J. Maloney, S. M. Larson, R. C. Reba
Journal of Nuclear Medicine Oct 1989, 30 (10) 1693-1701;
Reduction of Background Activities by Introduction of a Diester Linkage Between Antibody and a Chelate in Radioimmunodetection of Tumor
C.H. Paik, K. Yokoyama, J.C. Reynolds, S.M. Quadri, C.Y. Min, S.Y. Shin, P. J. Maloney, S. M. Larson, R. C. Reba
Journal of Nuclear Medicine Oct 1989, 30 (10) 1693-1701;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients: Comparison of Radiation Dosimetry for 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-Tetraacetic Acid (DOTA)-Peptide versus 2IT-DOTA Monoclonal Antibody Linkage for RIT
- High-Dose Therapy with 90Yttrium-labeled Monoclonal Antibody CC49: A Phase I Trial